Research Article

Oncologic Outcomes of Renal Cell Carcinoma Patients Undergoing Radical Nephrectomy and Venous Thrombectomy: Prospective Follow-Up from a Single Center

Table 2

Surgical and pathological outcomes of the study cohort.

CharacteristicsValue

Type of surgery
 Laparoscopic surgery130 (48.1)
 Open surgery140 (51.9)
 Adrenalectomy (/%)123 (45.6)
 Segmental resection of IVC (/%)45 (16.7)
 Resection of metastatic tumor (/%)4 (1.5)
 Operative time (min), median (IQR)320 (240-404)
 Blood loss (ml), median (IQR)700 (200-1800)
 Blood transfusion (/%) 1133llchmu109f136 (50.4)
 Packed RBC transfusion (ml), median (IQR)1200 (800-2000)
 FFP transfusion (ml), median (IQR)600 (400-800)
 Postoperative SCR98 (79-116)
 Complications (/%)88 (32.6)
 Cardiovascular or cerebrovascular events2 (0.7)
 Pneumonia or pleural effusion10 (3.7)
 Kidney insufficiency10 (3.7)
 Abdominal cavity infection4 (1.5)
 Incision infection2 (0.7)
 Deep venous thrombus23 (8.5)
 Anemia22 (8.1)
 Bowel obstruction16 (5.9)
 Lymphatic fistula9 (3.3)
 Death4 (1.5)
Clavien grade of complications (/%)
 I6 (2.2)
 II51 (18.9)
 III0
 IV11 (4.1)
 V4 (1.5)
Postoperative hospital stay (d), median (IQR)9 (6-12)
Histology (/%)
 Clear cell RCC225 (83.3)
 Papillary type RCC30 (11.1)
 Chromophobe RCC2 (0.7)
 Unclassified RCC7 (2.6)
 Squamous RCC1 (0.4)
 TFE-3 translocation RCC5 (1.9)
T stage
 pT3a50 (8.5)
 pT3b124 (45.9)
 pT3c80 (29.6)
 pT416 (5.9)
Lymph node metastasis93 (34.4)
Perinephric fat invasion73 (27.0)
Involving the venous wall (/%)58 (21.5)
Sarcomatoid differentiation30 (11.1)
Fuhrman grade (/%)
 15 (1.8)
 298 (36.3)
 3113 (41.9)
 454 (20.0)
Adjuvant therapy155 (57.4%)

RCC: renal cell carcinoma; IVT: inferior vena cava; RBC: red blood cells; FFP: fresh frozen plasma; ASA: American Society of Anesthesiologists; IQR: interquartile range; SCR: serum creatinine.